Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-015531
Filing Date
2024-11-13
Accepted
2024-11-13 16:16:55
Documents
65
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q gpcr-20240930x10q.htm   iXBRL 10-Q 2641555
2 EX-10.1 gpcr-20240930xex10d1.htm EX-10.1 79798
3 EX-10.2 gpcr-20240930xex10d2.htm EX-10.2 27864
4 EX-10.3 gpcr-20240930xex10d3.htm EX-10.3 35376
5 EX-31.1 gpcr-20240930xex31d1.htm EX-31.1 16251
6 EX-31.2 gpcr-20240930xex31d2.htm EX-31.2 16907
7 EX-32.1 gpcr-20240930xex32d1.htm EX-32.1 9955
8 EX-32.2 gpcr-20240930xex32d2.htm EX-32.2 10242
9 GRAPHIC gpcr-20240930x10q001.jpg GRAPHIC 62587
  Complete submission text file 0001558370-24-015531.txt   9106014

Data Files

Seq Description Document Type Size
10 EX-101.SCH gpcr-20240930.xsd EX-101.SCH 47304
11 EX-101.CAL gpcr-20240930_cal.xml EX-101.CAL 47316
12 EX-101.DEF gpcr-20240930_def.xml EX-101.DEF 204335
13 EX-101.LAB gpcr-20240930_lab.xml EX-101.LAB 465606
14 EX-101.PRE gpcr-20240930_pre.xml EX-101.PRE 349668
68 EXTRACTED XBRL INSTANCE DOCUMENT gpcr-20240930x10q_htm.xml XML 1426718
Mailing Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080 (628) 229-9277
Structure Therapeutics Inc. (Filer) CIK: 0001888886 (see all company filings)

EIN.: 981480821 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41608 | Film No.: 241454509
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)